Infleqtion | $100,000,000 | (Jun 3, 2025)
Moments Lab | $24,000,000 | (Jun 3, 2025)
LuminX | $5,500,000 | (Jun 3, 2025)
Certified by Founder
Lodge
Delphia Therapeutics
start up
United States
- Cambridge, Massachusetts
- 07/05/2024
- Series A
- $67,000,000
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.
- Industry Biotechnology Research
- Website https://www.delphiatx.com/
- LinkedIn https://www.linkedin.com/company/delphia-therapeutics/
Archil | $6,700,000 | (Jun 3, 2025)
Limited | $7,000,000 | (Jun 3, 2025)
Dexari | $2,300,000 | (Jun 3, 2025)
Heron Power | $38,000,000 | (Jun 3, 2025)
Trustifi | $25,000,000 | (Jun 3, 2025)
Literal Labs | $6,223,938 | (Jun 3, 2025)
Volteras | $11,100,000 | (May 30, 2025)
ROXFIT | $1,077,281 | (May 30, 2025)
Dream Park Immersive | $1,100,000 | (May 30, 2025)